Tag
Tag: Lymphoma
The Best of the Rest: What Else Happened at this Year’s ASH Conference?
New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients
This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected
The FDA Approves a Second CAR-T Therapy, Cheaper than Novartis’
Swiss ADCs Show Impressive Responses for Lymphoma in Phase I
French Biotech Announces Positive Phase I Results in T-cell Lymphoma
Update: MorphoSys Starts Phase III in Patients with Lymphoma
FDA Speeds Up the Approval Process for Bayer’s New Lymphoma Drug
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Janssen Stops Phase II Trial for a Danish Blood Cancer Blockbuster
